Search Results - "Taft, David"

Refine Results
  1. 1

    Spatial clustering and common regulatory elements correlate with coordinated gene expression by Zhang, Jingyu, Chen, Hengyu, Li, Ruoyan, Taft, David A, Yao, Guang, Bai, Fan, Xing, Jianhua

    Published in PLoS computational biology (01-03-2019)
    “…Many cellular responses to surrounding cues require temporally concerted transcriptional regulation of multiple genes. In prokaryotic cells, a…”
    Get full text
    Journal Article
  2. 2

    Application of Physiologically Based Pharmacokinetic‐Pharmacodynamic Modeling in Preterm Neonates to Guide Gentamicin Dosing Decisions and Predict Antibacterial Effect by Neeli, Harshith, Hanna, Nazeeh, Abduljalil, Khaled, Cusumano, Jaclyn, Taft, David R.

    Published in Journal of clinical pharmacology (01-10-2021)
    “…Clinical studies in preterm neonates are rarely performed due to ethical concerns and difficulties associated with trials and recruitment. Consequently, dose…”
    Get full text
    Journal Article
  3. 3

    Learn to segment single cells with deep distance estimator and deep cell detector by Wang, Weikang, Taft, David A., Chen, Yi-Jiun, Zhang, Jingyu, Wallace, Callen T., Xu, Min, Watkins, Simon C., Xing, Jianhua

    Published in Computers in biology and medicine (01-05-2019)
    “…Single cell segmentation is a critical and challenging step in cell imaging analysis. Traditional processing methods require time and labor to manually…”
    Get full text
    Journal Article
  4. 4

    Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populations by Jogiraju, Vamshi Krishna, Avvari, Suvarchala, Gollen, Rakesh, Taft, David R.

    Published in Biopharmaceutics & drug disposition (01-10-2017)
    “…Pregnancy is associated with numerous physiological changes that influence absorption, distribution, metabolism and excretion. Moreover, the magnitude of these…”
    Get full text
    Journal Article
  5. 5

    Physiologically based pharmacokinetic modeling of altered tizanidine systemic exposure by CYP1A2 modulation: Impact of drug-drug interactions and cigarette consumption by Jogiraju, Vamshi Krishna, Heimbach, Tycho, Toderika, Yuliana, Taft, David R.

    Published in Drug metabolism and pharmacokinetics (01-04-2021)
    “…Tizanidine is an alpha2-adrenergic agonist, used to treat spasticity associated with multiple sclerosis and spinal injury. Tizanidine is primarily metabolized…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    PBPK Modeling of Azithromycin Systemic Exposure in a Roux-en-Y Gastric Bypass Surgery Patient Population by Avvari, Suvarchala Kiranmai, Cusumano, Jaclyn A, Jogiraju, Vamshi Krishna, Manchandani, Pooja, Taft, David R

    Published in Pharmaceutics (01-10-2023)
    “…In this investigation, PBPK modeling using the Simcyp® Simulator was performed to evaluate whether Roux-en-Y gastric bypass (RYGB) surgery impacts the oral…”
    Get full text
    Journal Article
  10. 10

    Developing a Formulation Strategy Coupled with PBPK Modeling and Simulation for the Weakly Basic Drug Albendazole by Shah, Harsh, Shah, Kushal, Gajera, Bhavin, Dave, Rutesh H, Taft, David R

    Published in Pharmaceutics (23-03-2023)
    “…Albendazole (ABZ) is a weakly basic drug that undergoes extensive presystemic metabolism after oral administration and converts to its active form albendazole…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Effect of Gender on the Pharmacokinetics of ON 123300, A Dual Inhibitor of ARK5 and CDK4/6 for the Treatment of Cancer, in Rats by Mudunuru, Jennypher, Ren, Chen, Taft, David R., Maniar, Manoj

    “…Background and Objectives ON 123300, a small molecule dual inhibitor of the c-MYC activated kinases ARK5 and CDK4/6, is being developed as a novel drug…”
    Get full text
    Journal Article
  13. 13

    Evaluating the Potential for Delivery of Irinotecan via the Buccal Route: Physicochemical Characterization and In Vitro Permeation Assessment Across Porcine Buccal Mucosa by Shah, Vidhi, Bellantone, Robert A., Taft, David R.

    Published in AAPS PharmSciTech (01-04-2017)
    “…Irinotecan (CPT-11) is used to treat advanced colorectal cancer as an intravenous therapy. Depending on pH, CPT-11 exists in either a lactone (active) or…”
    Get full text
    Journal Article
  14. 14

    Real-World Experience With Higher-Than-Recommended Doses of Lamivudine in Patients With Varying Degrees of Renal Impairment by Fischetti, Briann, Shah, Kushal, Taft, David R, Berkowitz, Leonard, Bakshi, Anjali, Cha, Agnes

    Published in Open forum infectious diseases (01-10-2018)
    “…Although nucleoside reverse transcriptase inhibitors have been associated with lactic acidosis, lamivudine (3TC) has not been reported to have an increased…”
    Get full text
    Journal Article
  15. 15

    Radioprotective Effects of ON 01210.Na upon Oral Administration by Suman, Shubhankar, Datta, Kamal, Doiron, Kathryn, Ren, Chen, Kumar, Ramesh, Taft, David R, Fornace, Jr, Albert J, Maniar, Manoj

    Published in JOURNAL OF RADIATION RESEARCH (2012)
    “…ON 01210.Na (Ex-RAD), a chlorobenzylsulfone derivative was investigated for its pharmacologic and radioprotective properties when administered via oral and…”
    Get full text
    Journal Article
  16. 16

    Determination of intestinal permeability of rigosertib (ON 01910.Na, Estybon): correlation with systemic exposure by White, Michael P., Babayeva, Mariana, Taft, David R., Maniar, Manoj

    Published in Journal of pharmacy and pharmacology (01-07-2013)
    “…Objectives Rigosertib (ON 01910.Na, Estybon) is a novel, anticancer agent undergoing phase 3 clinical trials for a lead indication against myelodysplastic…”
    Get full text
    Journal Article
  17. 17

    Rapid, modular, and cost-effective generation of donor DNA constructs for CRISPR-based gene knock-in by Chen, Yi-Jiun, Cheng, Ya-Yun, Wang, Weikang, Tian, Xiao-Jun, Lefever, Daniel E, Taft, David A, Zhang, Jingyu, Xing, Jianhua

    Published in Biology methods and protocols (01-01-2020)
    “…Abstract Clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing techniques find applications in many fields, such as molecular…”
    Get full text
    Journal Article
  18. 18

    Disposition of ON 01210.Na (Ex-RAD(R)), a novel radioprotectant, in the isolated perfused rat liver: probing metabolic inhibition to increase systemic exposure by Tamhane, Mitalee, Maniar, Manoj, Ren, Chen, Benzeroual, Kenza E, Taft, David R

    Published in Journal of pharmaceutical sciences (01-02-2013)
    “…ON 01210.Na (Ex-RAD) is a novel benzyl styryl sulfone analog, developed as a radioprotectant by Onconova Therapeutics Inc. The objectives of this research were…”
    Get more information
    Journal Article
  19. 19

    Preclinical pharmacokinetics and in vitro activity of ON 01910.Na, a novel anti-cancer agent by Chun, Amy W., Cosenza, Stephen C., Taft, David R., Maniar, Manoj

    Published in Cancer chemotherapy and pharmacology (01-12-2009)
    “…Purpose ON 01910.Na is a novel targeted anti-cancer agent under clinical investigation in Phase I and II trials. The purpose of this research was to evaluate…”
    Get full text
    Journal Article
  20. 20

    Renal excretion of emtricitabine I: effects of organic anion, organic cation, and nucleoside transport inhibitors on emtricitabine excretion by Nakatani-Freshwater, Tomoko, Taft, David R

    Published in Journal of pharmaceutical sciences (01-12-2008)
    “…The excretion of emtricitabine (FTC) was characterized using isolated perfused rat kidney (IPK) model. Studies were performed to assess the dose-linearity of…”
    Get more information
    Journal Article